Telix to quote shares issued under non-executive director rights plan
TLX: $13.06 +2.11% · MC: $4.7B
Telix Pharmaceuticals has applied to quote ordinary shares issued under its Australian Non-Executive Director Rights Plan. The issue adds a small number of shares to the company’s existing quoted capital.

Comments